EUCTR2006-003327-36-GB进行中(未招募)1 期
Evaluation of the efficacy of colchicine with and without betamethasone mouthwash in the management of recurrent aphthous stomatitis - ART1
Guy's & St Thomas' NHS Foundation Trust0 个研究点目标入组 136 人开始时间: 2007年1月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 136
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients with RAS will be recruited from the oral medicine clinic.
- •1.Patients aged 18-65 years of age
- •2.Patients are willing and able to give informed consent to the study.
- •3.Patients will be asked if they are involved in any other research. Care will be taken to ensure that participation in multiple studies will not compromise patient safety or undermine the scientific basis of the study. The overall burden to the participants will be considered.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Patients under 18 years of age or over 65 years of age
- •2.Patients who do not adequately understand verbal explanations or written information given in English, or who have special communication needs and unable to give informed consent.
- •3.Patients who are pregnant or breast feeding.
- •4.Patients are unwilling or unable to comply with the study protocol
- •5.Patients with severe or relevant allergy history
- •6.Patients on systemic steroids
- •7.Patients who have been taking colchicine or betamethasone mouthwash in the previous three months.
- •8.Patients with a history of hypersensitivity to colchicine.
- •9.Patients with blood dyscrasias
- •10.Patients with a current or past history of any cardiac, renal, hepatic or gastrointestinal disease.
- •11.Patients who are debilitated in any way.
研究者
相似试验
招募中
3 期
Evaluation of colchicine in treatment of coronavirusPulmonary infection of COVD19.Coronavirus infection, unspecifiedB34.2IRCT20200418047126N1Ardabil University of Medical Sciences100
已完成
2 期
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1IRCT20200325046854N2Iran University of Medical Sciences70
招募中
3 期
Effect of Colchicine in patient presenting with non ST-elevation myocardial infarctioIRCT20190601043780N1Mashhad University of Medical Sciences140
招募中
3 期
Colchicine effects in patients with sepsisSepsis.Symptoms and signs specifically associated with systemic inflammation and infectionIRCT20231017059748N1Tabriz University of Medical Sciences44
招募中
2 期
Effect of Colchicine on aphthous ulceration.Aphthous.Recurrent oral aphthaeK12.0IRCT20160920029889N4Mazandaran University of Medical Sciences10
